Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Irinotecan Liposome in Combination With 5-FU/LV Versus 5-FU/LV in Second-line Therapy for Gemcitabine-Refractory Pancreatic Cancer [Phase 3]
Phase 3 trial update comparing irinotecan liposome plus 5-FU/LV versus 5-FU/LV alone as second-line therapy in gemcitabine-refractory pancre…
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating AZD0530 with gemcitabine in locally advanced or metastatic pancreatic cancer that is unresectable.
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene [Phase 1, Phase 2]
Phase 1/2 clinical trial studying A166 in patients with various HER2-expressing or HER2-amplified cancers has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: TAA Specific Cytotoxic T Lymphocytes in Patients With Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating tumor-associated antigen-specific cytotoxic T lymphocytes in pancreatic cancer has completed. Results we…
-
CLINICAL_TRIALS trial_result · 2023-07-25Clinical Trial Update: Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update for advanced pancreatic cancer with progression-free survival as a listed condition.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-07-13Clinical Trial Update: A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) [Phase 1, Phase 2]
Clinical trial update for KVA12123 as a standalone and in combination with pembrolizumab in advanced solid tumors; current status is unknown…
-
CLINICAL_TRIALS trial_result · 2023-07-11Clinical Trial Update: Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers [Phase 2]
Phase 2 clinical trial evaluating nivolumab with tadalafil and oral vancomycin in patients with refractory hepatocellular carcinoma or liver…
-
CLINICAL_TRIALS trial_result · 2023-07-10Clinical Trial Update: Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer [Phase 2]
Phase 2 trial update on combining CRS-207 with nivolumab and ipilimumab, with or without GVAX pancreas vaccine, in pancreatic cancer; the st…
-
CLINICAL_TRIALS trial_result · 2023-07-05Clinical Trial Update: Azacitidine and Pembrolizumab in Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating azacitidine in combination with pembrolizumab in pancreatic cancer has completed with results posted in July 2023.
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Niraparib + Dostarlimab + RT in Pancreatic Cancer [Phase 2]
Phase 2 trial results of Niraparib plus Dostarlimab with radiotherapy in pancreatic cancer have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Efficacy of Doxycycline on Metakaryote Cell Death in Patients With Resectable Pancreatic Cancer [Phase 2]
Phase 2 clinical trial assessing doxycycline for metakaryote cell death in patients with resectable pancreatic cancer; study completed with …
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor [Phase 2]
Phase 2 clinical trial evaluating FalateScan (Technetium Tc 99m EC20) for safety and efficacy in patients with suspected recurrent or metast…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Anlotinib Plus Anti-PD-1 Antibody AK105 for Advanced Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial update investigating the combination of Anlotinib with an Anti-PD-1 antibody (AK105) for advanced pancreatic cancer across Ph…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Neoadjuvant Plus Adjuvant or Only Adjuvant Nab- Paclitaxel Plus Gemcitabine for Resectable Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine in resectable pancreatic cancer has comp…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating chemotherapy and radiation therapy for locally advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas [Phase 2]
Phase 2 clinical trial update on combination chemotherapy for locally advanced or metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation [Phase 2]
Phase 2 trial evaluating rucaparib in pancreatic cancer patients with a deleterious BRCA mutation has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: Clinical Outcomes for Offering Genetic Testing in a Tiered Approach [NA]
A completed clinical trial evaluating the outcomes of offering genetic testing in a tiered approach, with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-05Clinical Trial Update: A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI) [Phase 4]
Phase 4 trial of Creon (pancrelipase) in pancreatic cancer patients with exocrine pancreatic insufficiency has been terminated; results post…
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]
Phase II trial evaluating gemcitabine and etoposide for locally advanced or metastatic pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy [Phase 1]
Phase 1 trial of a neoantigen peptide vaccine strategy in pancreatic cancer patients following surgical resection and adjuvant chemotherapy …
-
CLINICAL_TRIALS trial_result · 2023-05-22Clinical Trial Update: Terlipressin Infusion During Whipple Procedure: Effect on Blood Loss and Transfusion Needs [Phase 2]
Phase 2 trial update evaluating terlipressin infusion during Whipple procedure and its effect on blood loss and transfusion needs.
-
CLINICAL_TRIALS trial_result · 2023-05-19Clinical Trial Update: Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC): a Phase 2 Trial [Phase 2]
Phase 2 trial update evaluating Niraparib in metastatic pancreatic cancer after prior chemotherapy.
-
CLINICAL_TRIALS trial_result · 2023-05-15Clinical Trial Update: BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial investigating BATS with low-dose IL-1 and GM-CSF in advanced pancreatic cancer (Phase 1/2) has completed with results posted …
-
CLINICAL_TRIALS trial_result · 2023-05-12Clinical Trial Update: Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine [Phase 2]
Phase 2 trial comparing cardiovascular side effects of Teysuno versus capecitabine in gastrointestinal cancers completed.